Additionally, in a population-based case control study, patients who received combined therapy with insulin and metformin had a similar risk of stroke (OR, 0.98; 95% CI, 0.63–1.52) to those who treated with metformin in combination with a sulphonylurea. The gene discussed is INS; the disease is stroke disorder.